(Q57265404)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Natural killer clones recognize specific soluble HLA class I molecules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Giuseppe Terrazzano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Marco Colonna

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Loretta Tuosto

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

Piccolella E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Franksson L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Palazzolo G

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Pérez-Villar JJ

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Fontana S

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Kärre K

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Zappacosta S

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 March 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

683-689

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

Soluble HL-A7 Antigen: Localization in the β-Lipoprotein Fraction of Human Serum

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Anti HL-A2 Inhibitor in Normal Human Serum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Biochemical complexity of serum HLA class I molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Bioengineered soluble HLA-B7. Genesis, characterization, and occurrence of dimerization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

The Serologic Detection of HL-A Antigens in Human Milk

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Quantification of serum-soluble HLA class I antigens in patients with gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Quantitation of soluble HLA class I heterodimers and beta 2-microglobulin in patients with active pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Peroperative appearance of serum class I antigen during liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Inhibition of anti-HLA-B7 alloreactive CTL by affinity-purified soluble HLA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Interaction of papain-digested HLA class I molecules with human alloreactive cytotoxic T lymphocytes (CTL)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: estimation of the affinity of a T cell receptor for MHC

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

A soluble divalent class I major histocompatibility complex molecule inhibits alloreactive T cells at nanomolar concentrations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Class I transplantation antigens in solution in body fluids and in the urine. Individuality signals to the environment

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Susceptibility or resistance to lysis by alloreactive natural killer cells is governed by a gene in the human major histocompatibility complex between BF and HLA-B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Report of the second international soluble HLA (sHLA) workshop. Phoenix, Arizona, October 2, 1993.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Ly-49 mediates EL4 lymphoma adhesion to isolated class I major histocompatibility complex molecules

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Natural killer cells recognize common antigenic motifs shared by H-2Dd, H-2Ld and possibly H-2Dr molecules expressed on bone marrow cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with β2‐microglobulin

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Binding of diverse peptides to MHC class I molecules inhibits target cell lysis by activated natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Peptide specificity in the recognition of MHC class I by natural killer cell clones

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830260326

7 January 2021

Identifiers

DOI

10.1002/EJI.1830260326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8605938%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference